Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
04/2014
04/10/2014WO2014054053A1 Spirocyclic compounds, compositions and medicinal applications thereof
04/10/2014US20140100364 Compounds Useful For Making HCV Protease Inhibitors
04/10/2014US20140100248 Novel Heterocyclic Compounds as Modulators of Sphingolipid Signaling and Uses Thereof
04/10/2014US20140100223 Compounds and methods for the treatment of isocitrate dehydrogenase related diseases
04/10/2014US20140100216 Stimulators of incretin hormones secretion, method for preparation and use thereof
04/10/2014US20140100193 Diazonamide Analogs
04/09/2014EP2714697A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
04/09/2014EP2714660A1 Neprilysin inhibitors
04/09/2014CN103717598A Fused heterocyclic compound and use thereof for pest control
04/09/2014CN103709195A Chiral sulfinylamine monophosphine, and full-configuration preparation method and application thereof
04/09/2014CN103709177A Rifamycin and valnemulin hybrid antibiotic and preparation method thereof
04/09/2014CN103709176A Reagents and method for separation of ofloxacin racemic mixture by utilization of ionic liquid and L-dibenzoyltartaric acid together
04/09/2014CN103709175A One-step synthesis method of 6-chlorine-3H-oxazole [4,5-b] pyridine-2-ketone
04/09/2014CN103709174A One-step synthesis method of 6-bromo-3H-oxazolo [4,5-b] pyridine-2-ketone
04/09/2014CN103709154A Benzimidazole derivatives, preparation method and medicinal use thereof
04/09/2014CN103709122A Antitumor and antifungal compound for treatment
04/09/2014CN103709093A Combined-ring-containing pleuromutilin antibiotics
04/09/2014CN102491985B Synthesis method for 6-amino-2,2-dimethyl-2H-pyridino-[3,2-b] [1,4] oxazine-3(4H)-ketone
04/09/2014CN102351881B Stable levofloxacin hydrochloride compound
04/09/2014CN101443314B Aminoquinolones as GSK-3 inhibitors
04/08/2014US8691864 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
04/08/2014CA2563607C 4,5-disubstituted-2-aryl pyrimidines
04/03/2014WO2014052537A1 Improved methods for the acylation of maytansinol
04/03/2014WO2014052387A1 Tricyclic tetrahydroquinoline antibacterial agents
04/03/2014WO2014051165A1 Tetrazolinone compounds and their use as pesticides
04/03/2014US20140094608 Modified carbocyanine dyes and their conjugates
04/03/2014US20140094462 Sonic hedgehog modulators
04/03/2014US20140094456 Anti-fibrotic pyridinones
04/02/2014EP2712867A1 Compositions of tetrazole derivatives of sirolimus and anti-oxidants
04/02/2014CN103703009A Novel compounds as diacylglycerol acyltransferase inhibitors
04/02/2014CN103703008A (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists
04/02/2014CN103694255A Pyridinooxazone-pyridinopyrimidone compounds and preparation method and application thereof
04/02/2014CN103694191A Polyfunctional group nitrile resin monomer and polymer and preparation method thereof
04/02/2014CN102633583B Method of using oligonucleotide for chiral drug resolution
04/02/2014CN102143750B Macrocyclics pyrimidines as aurora kinase inhibitors
04/01/2014US8685995 Treatment with opioid antagonists and mTOR inhibitors
04/01/2014US8685920 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
03/2014
03/27/2014WO2014047390A1 Tricyclic heterocyclic compounds as notch inhibitors
03/27/2014WO2014022378A3 Naphthobisazole diimide based n-tvpe organic semiconductors
03/27/2014US20140088093 Tricyclic tetrahydroquinoline antibacterial agents
03/27/2014US20140088088 Anti-cancer activity of novel bicyclic heterocycles
03/26/2014EP2711368A1 Benzoxazepin PI3K inhibitor compounds and methods of use
03/26/2014EP2711351A1 Low catalyst loading in metathesis reactions
03/26/2014EP2710015A1 Polymorph of rifaximin and process for the preparation thereof
03/26/2014EP2710014A1 New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
03/26/2014EP2710013A1 Novel compounds as diacylglycerol acyltransferase inhibitors
03/26/2014CN103664999A Chiral synthetic method of temsirolimus
03/26/2014CN103664998A Split reagent and method for ofloxacin racemic mixture
03/26/2014CN103664973A Spiro-oxindole compounds and their use as therapeutic agents
03/26/2014CN103664907A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664802A Quinazoline analogs as receptor tyrosine kinase inhibitors
03/26/2014CN102083839B Compounds
03/25/2014US8680111 Macrocyclic derivatives for the treatment of diseases
03/25/2014US8680089 Fused pyridine derivatives
03/25/2014US8680079 Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitors
03/25/2014US8679776 Activatable dyes
03/25/2014CA2618741C Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
03/25/2014CA2541086C Process for making amide acetals
03/20/2014WO2014043272A1 Tricyclic gyrase inhibitors for use as antibacterial agents
03/20/2014WO2014041175A1 Novel inhibitor compounds of phosphodiesterase type 10a
03/20/2014WO2014041125A1 Specific inhibitors of protein p21 as therapeutic agents
03/20/2014US20140081016 Regioselective acylation of rapamycin at the c-42 position
03/20/2014US20140080823 Spirocyclic derivatives as histone deacetylase inhibitors
03/20/2014US20140080822 Tricyclic Pyrazole Sulphonamide Compounds and Methods of Making and Using Same
03/20/2014US20140080821 Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor
03/20/2014US20140080809 Novel Compounds as Diacylglycerol Acyltransferase Inhibitors
03/20/2014US20140080804 Novel 6-arylamino pyridone carboxamide as mek inhibitors
03/20/2014US20140080801 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/19/2014EP2707373A1 Bicyclic (thio)carbonylamidines
03/19/2014EP2707362A1 Process
03/19/2014CN103649060A Process
03/19/2014CN103641844A Preparation method of low content 25-deacetyl rifamycin S
03/19/2014CN103641823A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8674104 Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof
03/18/2014US8674103 Lyotropic liquid crystal systems based on aromatic tetracarboxylic bisbenzoimidazole derivatives and methods for making
03/18/2014US8673936 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
03/18/2014US8673931 Bicyclic heterocyclic spiro compounds
03/18/2014US8673900 Gamma secretase modulators
03/18/2014CA2663509C Process for preparing n-alkyl naltrexone halides
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014015167A3 5,5-heteroaromatic anti-infective compounds
03/13/2014WO2013184876A8 Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
03/13/2014US20140073647 Novel fluoroergoline analogs
03/13/2014US20140073631 Antiviral and antimicrobial compounds
03/13/2014US20140073629 Alkoxy pyrazoles as soluble guanylate cyclase activators
03/13/2014US20140073623 Tricyclic Sulfonamide Compounds and Methods of Making and Using Same
03/12/2014EP2706061A1 A chemo-enzymatic approach to the synthesis of pimecrolimus
03/12/2014EP2705043A1 Processes and intermediates in the preparation of morphine analogs via n-demethylation of n-oxides using cyclodehydration reagents
03/12/2014EP2705042A1 Rifaximin dimethylformamide solvate
03/12/2014EP2705036A1 Tricyclic sulfonamide compounds and methods of making and using same
03/12/2014EP2705035A1 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
03/12/2014CN103635467A Oxazepines as ion channel modulators
03/12/2014CN103626762A Benazepine compound and application thereof
03/12/2014CN103626761A Benazepine compound and application thereof as antitumor drug
03/12/2014CN102718777B Method for preparing iodo sirolimus crystals
03/11/2014US8669362 Processes and Intermediates for carbamoylpyridone HIV integrase inhibitors
03/11/2014US8669360 Methods of converting amorphous drug substance into crystalline form
03/11/2014US8669269 Imidazopyridine derivatives which inhibit the secretion of gastric acid
03/11/2014US8669251 8-fluorophthalazin-1(2H)-one compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 220